Nicotine therapeutic benefits: Difference between revisions

Line 1,141:

**Citation: Chaoran Ma, Samantha Molsberry, Yanping Li, Michael Schwarzschild, Alberto Ascherio, Xiang Gao, Dietary nicotine intake and risk of Parkinson disease: a prospective study, The American Journal of Clinical Nutrition, Volume 112, Issue 4, October 2020, Pages 1080–1087, doi: 10.1093/ajcn/nqaa186

***Acknowledgements: Supported by National Institute of Neurological Disorders and Stroke at the NIH grant 1R03NS093245-01A1 (to XG). The Nurses’ Health Study is supported by the NIH through grant UM1 CA186107. The Health Professionals Follow-up Study cohort is supported by the NIH through grant U01 CA167552.

===2017 [https://academic.oup.com/ije/article/46/3/872/2656164 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]===

*Non-smoking men who used snus had a 60% lower risk of Parkinson’s disease compared with never snus users.

**Citation: Yang F, Pedersen NL, Ye W, Liu Z, Norberg M, Forsgren L, Trolle Lagerros Y, Bellocco R, Alfredsson L, Knutsson A, Jansson JH, Wennberg P, Galanti MR, Lager ACJ, Araghi M, Lundberg M, Magnusson C, Wirdefeldt K. Moist smokeless tobacco (Snus) use and risk of Parkinson's disease. Int J Epidemiol. 2017 Jun 1;46(3):872-880. doi: 10.1093/ije/dyw294. PMID: 27940486.

***Acknowledgement: This work was supported by the Swedish Research Council (grant number 521-2013-2488 to N.L.P.) and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (Y.T.L.).

===2016: [https://truthinitiative.org/sites/default/files/media/files/2019/08/ReThinking-Nicotine_0.pdf Re-thinking nicotine and its effects]===

@@ Line 1,141: / Line 1,141: @@
 **Citation: Chaoran Ma, Samantha Molsberry, Yanping Li, Michael Schwarzschild, Alberto Ascherio, Xiang Gao, Dietary nicotine intake and risk of Parkinson disease: a prospective study, The American Journal of Clinical Nutrition, Volume 112, Issue 4, October 2020, Pages 1080–1087, doi: 10.1093/ajcn/nqaa186
 ***Acknowledgements: Supported by National Institute of Neurological Disorders and Stroke at the NIH grant 1R03NS093245-01A1 (to XG). The Nurses’ Health Study is supported by the NIH through grant UM1 CA186107. The Health Professionals Follow-up Study cohort is supported by the NIH through grant U01 CA167552.
+===2017 [https://academic.oup.com/ije/article/46/3/872/2656164 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]===
+*Non-smoking men who used snus had a 60% lower risk of Parkinson’s disease compared with never snus users.
+**Citation: Yang F, Pedersen NL, Ye W, Liu Z, Norberg M, Forsgren L, Trolle Lagerros Y, Bellocco R, Alfredsson L, Knutsson A, Jansson JH, Wennberg P, Galanti MR, Lager ACJ, Araghi M, Lundberg M, Magnusson C, Wirdefeldt K. Moist smokeless tobacco (Snus) use and risk of Parkinson's disease. Int J Epidemiol. 2017 Jun 1;46(3):872-880. doi: 10.1093/ije/dyw294. PMID: 27940486.
+***Acknowledgement: This work was supported by the Swedish Research Council (grant number 521-2013-2488 to N.L.P.) and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (Y.T.L.).
 ===2016: [https://truthinitiative.org/sites/default/files/media/files/2019/08/ReThinking-Nicotine_0.pdf Re-thinking nicotine and its effects]===